Analysts Offer Insights on Healthcare Companies: Kura Oncology (KURA), Tenaya Therapeutics (TNYA) and PepGen Inc. (PEPG)
Kura Oncology Analyst Ratings
Express News | HC Wainwright & Co. Reiterates Buy on Kura Oncology, Maintains $32 Price Target
Analysts Offer Insights on Healthcare Companies: Kura Oncology (KURA) and Aquestive Therapeutics (AQST)
Express News | Cantor Fitzgerald Reiterates Overweight on Kura Oncology
Kura Oncology Price Target Maintained With a $37.00/Share by Wedbush
Kura Oncology (KURA) Gets a Buy From Stifel Nicolaus
Scotiabank Reaffirms Their Hold Rating on Kura Oncology (KURA)
Express News | Stifel Maintains Buy on Kura Oncology, Lowers Price Target to $26
Buy Rating Affirmed for Kura Oncology Amid Positive Clinical and Financial Developments
Express News | Kura Oncology Inc : Stifel Cuts Target Price to $26 From $28
Positive Outlook for Kura Oncology as Ziftomenib Shows Promise in AML Treatment and Expands Clinical Trials
Express News | Kura Oncology Inc: $491.5 Mln in Cash, Cash Equivalents and Investments Provide Runway Into 2027
Express News | Kura Oncology Q2 2024 GAAP EPS $(0.59) Beats $(0.63) Estimate
Kura Oncology | 10-Q: Q2 2024 Earnings Report
Express News | Kura Oncology Reports Second Quarter 2024 Financial Results
Express News | Kura Oncology Q2 Operating Expenses USD 56.404 Million
Express News | Kura Oncology Q2 Net Income USD -50.837 Million
Kura Oncology 2Q Loss/Shr 59c >KURA
Press Release: Kura Oncology Reports Second Quarter 2024 Financial Results